Obstacles and opportunities in new drug development

被引：40
|
作者：
Kaitin, K. I. [1 ]
机构：
[1] Tufts Univ, Sch Med, Tufts Ctr Study Drug Dev, Boston, MA 02111 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷 / 02期
关键词：
D O I：
10.1038/sj.clpt.6100462
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：210 / 212
页数：3
相关论文
共 50 条
  • [31] Toll-like receptor agonists: New opportunities for drug development
    Wagner, Hermann
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (01): : 58 - 58
  • [32] THE PARASITOPHOROUS DUCT PATHWAY - NEW OPPORTUNITIES FOR ANTIMALARIAL DRUG AND VACCINE DEVELOPMENT
    TARASCHI, TF
    NICOLAS, E
    PARASITOLOGY TODAY, 1994, 10 (10): : 399 - 401
  • [33] New Zealand's drug development industry-strengths and opportunities
    Lockhart, Michelle M.
    Babar, Zaheer U-D
    Garg, Sanjay
    NEW ZEALAND MEDICAL JOURNAL, 2010, 123 (1317) : 52 - 58
  • [34] Structurally novel AMPA potentiators: New opportunities for drug development.
    Zimmerman, DM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U5 - U5
  • [35] New drug development for cognitive enhancement in mental health: Challenges and opportunities
    Insel, Thomas
    Krystal, John
    Ehlers, Michael
    NEUROPHARMACOLOGY, 2013, 64 : 2 - 7
  • [36] OPPORTUNITIES AND OBSTACLES.
    Anon
    Practical lubrication & maintenance, 1986, 9 (04): : 24 - 26
  • [37] Rifamycins - Obstacles and opportunities
    Aristoff, Paul A.
    Garcia, George A.
    Kirchhoff, Paul D.
    Showalter, H. D. Hollis
    TUBERCULOSIS, 2010, 90 (02) : 94 - 118
  • [38] OPPORTUNITIES, OBLIGATIONS AND OBSTACLES
    VARDON, S
    AUSTRALIAN JOURNAL OF PUBLIC ADMINISTRATION, 1987, 46 (02) : 142 - 145
  • [39] Obstacles can be opportunities
    Preston, SM
    CHEMICAL ENGINEERING PROGRESS, 2000, 96 (03) : 7 - 8
  • [40] Introducing new vaccines into developing countries: obstacles, opportunities and complexities
    John Clemens
    Luis Jodar
    Nature Medicine, 2005, 11 : S12 - S15
12345